Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

54 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Melanoma: from darkness to promise.
Gasent Blesa JM, Grande Pulido E, Alberola Candel V, Provencio Pulla M. Gasent Blesa JM, et al. Among authors: provencio pulla m. Am J Clin Oncol. 2011 Apr;34(2):179-87. doi: 10.1097/COC.0b013e3181d6b427. Am J Clin Oncol. 2011. PMID: 20498590 Review.
Circulating tumor cells in breast cancer: methodology and clinical repercussions.
Gasent Blesa JM, Alberola Candel V, Esteban González E, Vidal Martínez J, Gisbert Criado R, Provencio Pulla M, Laforga Canales J, Pachmann K. Gasent Blesa JM, et al. Among authors: provencio pulla m. Clin Transl Oncol. 2008 Jul;10(7):399-406. doi: 10.1007/s12094-008-0222-9. Clin Transl Oncol. 2008. PMID: 18628068 Review.
Spanish Society of Medical Oncology consensus on the use of erythropoietic stimulating agents in anaemic cancer patients.
Alberola Candel V, Carrato Mena A, Díaz-Rubio García E, Gascón Vilaplana P, González Barón M, Martín Jiménez M, Alba Conejo E, Cassinello Espinosa J, Colomer R, Cruz Hernández JJ, Barnadas i Molins A, Camps Herrero C, Casas Fernández de Tejerina AM, Carulla Torrent J, Constenla Figueiras M, Gavilá Gregori J, Isla Casado MD, Massuti Sureda B, Provencio Pulla M, Rodríguez Sánchez CA, Sanz Ortiz J; Spanish Society of Medical Oncology. Alberola Candel V, et al. Among authors: provencio pulla m. Clin Transl Oncol. 2009 Nov;11(11):727-36. doi: 10.1007/s12094-009-0435-6. Clin Transl Oncol. 2009. PMID: 19917536
Experience with fulvestrant acetate in castration-resistant prostate cancer patients.
Gasent Blesa JM, Alberola Candel V, Giner Marco V, Giner-Bosch V, Provencio Pulla M, Laforga Canales JB. Gasent Blesa JM, et al. Among authors: provencio pulla m. Ann Oncol. 2010 May;21(5):1131-2. doi: 10.1093/annonc/mdq010. Epub 2010 Feb 5. Ann Oncol. 2010. PMID: 20139153 Free article. No abstract available.
Old and new insights in the treatment of thyroid carcinoma.
Gasent Blesa JM, Grande Pulido E, Provencio Pulla M, Alberola Candel V, Laforga Canales JB, Grimalt Arrom M, Martin Rico P. Gasent Blesa JM, et al. Among authors: provencio pulla m. J Thyroid Res. 2010 Apr 13;2010:279468. doi: 10.4061/2010/279468. J Thyroid Res. 2010. PMID: 21048836 Free PMC article.
Phase II trial of concomitant neoadjuvant chemotherapy with oxaliplatin and capecitabine and intensity-modulated radiotherapy (IMRT) in rectal cancer.
Gasent Blesa JM, Garde Noguera J, Laforga Canales JB, Giner Bosch V, Alberola A, Soler Tortosa M, Peris Godoy M, Sanchez JL, Provencio Pulla M, Alberola Candel V. Gasent Blesa JM, et al. Among authors: provencio pulla m. J Gastrointest Cancer. 2012 Dec;43(4):553-61. doi: 10.1007/s12029-012-9364-7. J Gastrointest Cancer. 2012. PMID: 22371167 Clinical Trial.
Consolidation nivolumab and ipilimumab versus observation in limited-disease small-cell lung cancer after chemo-radiotherapy - results from the randomised phase II ETOP/IFCT 4-12 STIMULI trial.
Peters S, Pujol JL, Dafni U, Dómine M, Popat S, Reck M, Andrade J, Becker A, Moro-Sibilot D, Curioni-Fontecedro A, Molinier O, Nackaerts K, Insa Mollá A, Gervais R, López Vivanco G, Madelaine J, Mazieres J, Faehling M, Griesinger F, Majem M, González Larriba JL, Provencio Pulla M, Vervita K, Roschitzki-Voser H, Ruepp B, Mitchell P, Stahel RA, Le Pechoux C, De Ruysscher D; ETOP/IFCT 4-12 STIMULI Collaborators. Peters S, et al. Among authors: provencio pulla m. Ann Oncol. 2022 Jan;33(1):67-79. doi: 10.1016/j.annonc.2021.09.011. Epub 2021 Sep 23. Ann Oncol. 2022. PMID: 34562610 Free article. Clinical Trial.
Lenalidomide plus R-GDP (R2-GDP) in Relapsed/Refractory Diffuse Large B-Cell Lymphoma: Final Results of the R2-GDP-GOTEL Trial and Immune Biomarker Subanalysis.
Palazón-Carrión N, Martín García-Sancho A, Nogales-Fernández E, Jiménez-Cortegana C, Carnicero-González F, Ríos-Herranz E, de la Cruz-Vicente F, Rodríguez-García G, Fernández-Álvarez R, Martínez-Banaclocha N, Gumà-Padrò J, Gómez-Codina J, Salar-Silvestre A, Rodríguez-Abreu D, Gálvez-Carvajal L, Labrador J, Guirado-Risueño M, García-Domínguez DJ, Hontecillas-Prieto L, Espejo-García P, Fernández-Román I, Provencio-Pulla M, Sánchez-Beato M, Navarro M, Marylene L, Álvaro-Naranjo T, Casanova-Espinosa M, Sánchez-Margalet V, Rueda-Domínguez A, de la Cruz-Merino L. Palazón-Carrión N, et al. Among authors: provencio pulla m. Clin Cancer Res. 2022 Sep 1;28(17):3658-3668. doi: 10.1158/1078-0432.CCR-22-0588. Clin Cancer Res. 2022. PMID: 35727601 Free PMC article. Clinical Trial.
54 results